AC Immune ACIU
NASDAQ ACIU
$2.60 -0.02 (-0.81%)
As of: Oct 1, 2026 · 10:09 AM EDT

AC Immune (ACIU) Other Non-Current Assets (2021)

Updated

AC Immune (ACIU) reported Other Non-Current Assets of $4.82 million for the quarter ended Sep 30, 2021.

Analysis

AC Immune (ACIU) Other Non-Current Assets (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 AC Immune 266.56 Mn 266.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 4.82 Mn
API Access

AC Immune Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACIU&period=max&api_key=YOUR_API_KEY